Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
2,655
NCT04397510
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
Phase: Phase 4
Role: Lead Sponsor
Start: Jun 1, 2020
Completion: Dec 31, 2021
NCT04635241
Inhaled Heparin for Hospitalised COVID-19 Patients
Phase: Phase 2/3
Role: Collaborator
Completion: Jan 18, 2025
NCT04723563
Nebulized Heparin for the Treatment of COVID-19
Start: Feb 22, 2021
Completion: Aug 23, 2021
NCT05112315
Clinical Impact of the IBox As an Early Intervention TooL
Phase: N/A
Start: Feb 18, 2022
Completion: Feb 28, 2025
NCT05434416
The Efficacy of a Mobile Application in Reducing Craving and Lapse Risk in Alcohol and Stimulants Problematic Use
Start: Jun 21, 2022
Completion: Feb 28, 2023
NCT05434429
Mobile Health for Problematic Behaviors and Substance Use
NCT05730504
Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder
Start: Mar 5, 2023
Completion: Jun 30, 2023